Title of article
Triamcinolone Acetonide Oromucoadhesive Paste for Treatment of Aphthous Stomatitis
Author/Authors
HamishehKar، Hamed نويسنده , , Nokhodchi، Ali نويسنده , , Ghanbarzadeh، Saeed نويسنده Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. , , Kouhsoltani، Maryam نويسنده Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran. ,
Issue Information
دوفصلنامه با شماره پیاپی 0 سال 2015
Pages
6
From page
277
To page
282
Abstract
Purpose: The aim of this study was to prepare the optimized oral paste formulation of
Triamcinolone acetonide intended to be used in aphtous stomatitis.
Methods: Plastibases were prepared using mineral oil and polyethylene (95:5). Oral paste
formulations were prepared with different mixtures of three hydrocolloids solids, including
gelatin, pectin and sodium carboxymethylcellulose, with different ratios, as well as
Plastibase. Long-term and short-term stability of prepared formulations were studied in the
case of color and consistency of pastes. Franz diffusion cell and dialysis membrane were
employed for release study. Release data were fitted in the kinetic models to find out the
mechanism of drug release.
Results: Formulation containing 60% plastibase, 3.3% pectin, 6.6% gelatin and 30%
carboxymethylcellulose showed desired durability of adhesion, spreadability and rheology
property in healthy volunteers and was compared with reference formulation (Adcortyl®) in
the case of release profile. Although, optimized formulation and Adcortyl followed the
Higuchi and first order release kinetics respectively, optimized formulation showed similar
release profile to reference formulation.
Conclusion: Optimized oral paste formulation of Triamcinolone Acetonide showed similar
characteristics with reference formulation and could be used as an effective drug delivery
system for the treatment of recurrent aphthous stomatitis.
Journal title
Advanced Pharmaceutical Bulletin
Serial Year
2015
Journal title
Advanced Pharmaceutical Bulletin
Record number
2123235
Link To Document